Klimo Paul, Thompson Clinton J, Kestle John R W, Schmidt Meic H
Department of Neurosurgery, University of Utah, Salt Lake City, UT 84108, USA.
Neuro Oncol. 2005 Jan;7(1):64-76. doi: 10.1215/S1152851704000262.
Radiotherapy has been the primary therapy for managing metastatic spinal disease; however, surgery that decompresses the spinal cord circumferentially, followed by reconstruction and immediate stabilization, has also proven effective. We provide a quantitative comparison between the "new" surgery and radiotherapy, based on articles that report on ambulatory status before and after treatment, age, sex, primary neoplasm pathology, and spinal disease distribution. Ambulation was categorized as "success" or "rescue" (proportion of patients ambulatory after treatment and proportion regaining ambulatory function, respectively). Secondary outcomes were also analyzed. We calculated cumulative success and rescue rates for our ambulatory measurements and quantified heterogeneity using a mixed-effects model. We investigated the source of the heterogeneity in both a univariate and multivariate manner with a meta-regression model. Our analysis included data from 24 surgical articles (999 patients) and 4 radiation articles (543 patients), mostly uncontrolled cohort studies (Class III). Surgical patients were 1.3 times more likely to be ambulatory after treatment and twice as likely to regain ambulatory function. Overall ambulatory success rates for surgery and radiation were 85% and 64%, respectively. Primary pathology was the principal factor determining survival. We present the first known formal meta-analysis using data from nonrandomized clinical studies. Although we attempted to control for imbalances between the surgical and radiation groups, significant heterogeneity undoubtedly still exists. Nonetheless, we believe the differences in the outcomes indicate a true difference resulting from treatment. We conclude that surgery should usually be the primary treatment with radiation given as adjuvant therapy. Neurologic status, overall health, extent of disease (spinal and extraspinal), and primary pathology all impact proper treatment selection.
放射治疗一直是转移性脊柱疾病的主要治疗方法;然而,对脊髓进行环形减压、随后进行重建并立即稳定的手术也已证明是有效的。我们根据报道治疗前后活动状态、年龄、性别、原发性肿瘤病理以及脊柱疾病分布的文章,对“新”手术和放射治疗进行了定量比较。活动能力分为“成功”或“挽救”(分别为治疗后能够行走的患者比例和恢复行走功能的比例)。还分析了次要结果。我们计算了活动能力测量的累积成功率和挽救率,并使用混合效应模型对异质性进行了量化。我们使用元回归模型以单变量和多变量方式研究了异质性的来源。我们的分析纳入了24篇手术相关文章(999例患者)和4篇放射治疗相关文章(543例患者)的数据,大多为非对照队列研究(III级)。手术患者治疗后能够行走的可能性是放射治疗患者的1.3倍,恢复行走功能的可能性是放射治疗患者的两倍。手术和放射治疗的总体活动成功率分别为85%和64%。原发性病理是决定生存的主要因素。我们使用非随机临床研究的数据进行了首次已知的正式荟萃分析。尽管我们试图控制手术组和放射治疗组之间的不平衡,但无疑仍存在显著的异质性。尽管如此,我们认为结果的差异表明治疗导致了真正的差异。我们得出结论,手术通常应作为主要治疗方法,放射治疗作为辅助治疗。神经学状态、整体健康状况、疾病范围(脊柱和脊柱外)以及原发性病理都会影响正确的治疗选择。